Sarah Cannon Research Institute shared a post on LinkedIn:
“In a recent episode of Oncology Decoded, SCRI’s Dr. Manoj Bupathi, Chair of the Genitourinary Cancer Research Executive Committee for SCRI at Rocky Mountain Cancer Centers, and Dr. Benjamin Garmezy, Associate Director of Genitourinary Cancer Research for SCRI and Medical Oncologist at SCRI Oncology Partners, contribute their expertise to a timely discussion on how AI is influencing cancer research and care delivery.
Their insights highlight both the promise of these emerging technologies and the importance of integrating them thoughtfully into clinical practice to support physicians and patients alike.
You can also read: Sarah Cannon Research Institute and Merck Collaborate to Expand Access to Oncology Clinical Trials
